Medscint
Medscint is a Quebec-based medical device company developing plastic scintillation dosimetry systems (HYPERSCINT platform) for real-time radiotherapy quality assurance, serving clinical medical physicists and radiation oncology researchers across 15 countries.
- Company typePrivate
- Founded2018
- HeadquartersQuebec, Canada
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Medscint does
Medscint is a Quebec-based medical device company founded in 2018 that develops plastic scintillation dosimetry solutions for radiotherapy quality assurance. Its core technology is a proprietary hyperspectral scintillation dosimetry approach that differentiates between scintillation and Cherenkov emissions, enabling Cherenkov-free, real-time, multi-point dose measurements without stem-effect interference. The company's product architecture is anchored on the HYPERSCINT platform, comprising the HYPERSCINT QA medical device (the company's first commercially distributed medical device, available in the US, Japan, and South Korea), the HYPERSCINT RP-200 research platform for time-resolved dosimetry in adaptive radiotherapy and MR-LINAC settings, and the HYPERSCINT RP-FLASH for ultra-high dose-rate (FLASH) applications. These are complemented by a modular detector family (PRO, MICRO, FLEX, FLASH, MODULES) supporting specialized use cases such as sub-millimeter small fields, in-catheter measurements, and integration with the IBA QUASAR MRI4D Motion Phantom for MR-guided radiotherapy QA.
The company sells hardware directly to clinical and research customers through enterprise sales and contact-driven engagement, complemented by regional distribution partnerships covering South Korea (EnergyFlow), Italy (DosimETrICA), Spain (Fimecorp), BENELUX (Radicare), and the UK/general (OSL). Pricing is quote-based and not publicly disclosed. Customer segments are primarily clinical medical physicists at hospitals and academic medical centers conducting advanced radiotherapy research, with a secondary segment of FLASH and proton therapy research groups. As of late 2025, Medscint reports HYPERSCINT solutions deployed across 15 countries, with named customers spanning academic institutions (University of Maryland, UC Davis, University of Victoria, University of Galway) and hospital systems (CHU de Québec–Université Laval, Odense University Hospital, Hôpital général juif). The company employs approximately 12 team members led by co-founder François Therriault-Proulx, with deep in-house technical depth across medical physics, optical engineering, and software development, supported by strategic R&D and clinical partnerships with Université Laval and CHU de Québec.
Medscint firmographics
Firmographics- Name
- Medscint
- Legal name
- Medscint
- Website
- https://medscint.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Medscint is a Quebec-based medical device company developing plastic scintillation dosimetry systems (HYPERSCINT platform) for real-time radiotherapy quality assurance, serving clinical medical physicists and radiation oncology researchers across 15 countries.
- Ownership category
- akta.pro rank
Medscint industry classification
Industry- Product category
- Radiotherapy Dosimetry Equipment
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)
- akta.pro secondary industry
- Quality, Peer Review & Compliance Tools (MQSA/ACR/QA) (HLACALAL)
Keywords
Where Medscint is headquartered
LocationHeadquarters
- HQ city
- Quebec
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Medscint business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Marketing or Sales, Supply Chain, Personnel, Operations
Revenue model
- Medical Device Sales (HYPERSCINT QA): Sale of HYPERSCINT QA medical device for radiotherapy quality assurance in clinical settings. Commercial distribution in US, Japan, and South Korea.
- Research Platform Sales (HYPERSCINT RP-200 and RP-FLASH): Sale of research-grade dosimetry platforms and accessories for research institutions. Available for research purpose distribution globally.
- Custom Detector Solutions: Customized detectors aligned with specific research requirements, offering modular platform solutions for specialized applications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for HYPERSCINT QA system |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels5 records
Medscint product offering
Product offeringCore offering
Medscint designs, manufactures, and sells plastic scintillation dosimetry systems for radiotherapy quality assurance. Its flagship HYPERSCINT QA is a 2-channel medical device for clinical small-field dosimetry and End-to-End QA, commercially distributed in the United States, Japan, and South Korea. The HYPERSCINT Research Platform (RP-200 and RP-FLASH variants) provides turnkey, real-time, multi-point dosimetry for advanced radiotherapy research including MR-LINAC, Adaptive-RT, and FLASH (Ultra-High Dose-Rate) applications. The portfolio is complemented by a modular detector series (PRO, MICRO, FLEX, FLASH, MODULES) and the HYPERDOSE QA Software for real-time visualization.
Product overview
Medscint is a Quebec-based manufacturer of medical radiation therapy devices and a leader in plastic scintillation dosimetry solutions. The company offers a platform-plus-products architecture anchored by the HYPERSCINT technology platform, which uses proprietary hyperspectral technology combined with plastic scintillators, optics, and photonic systems. The core product family includes HYPERSCINT QA (medical device for clinical use), HYPERSCINT RP-200 (research platform for advanced applications), and HYPERSCINT RP-FLASH (specialized for FLASH/UHDR radiotherapy). These are complemented by modular detector series (PRO, MICRO, FLEX, FLASH, MODULES) that provide specialized capabilities for different measurement scenarios. The platform provides water-equivalent, MRI-safe, energy-independent, angle-independent, dose rate-independent, real-time, multi-point dosimetry for quality assurance in radiotherapy.
Differentiator
Problem solved
Functional benefit
Products and services
- HYPERSCINT QA A medical device providing next-generation dosimetry quality assurance for radiotherapy. Features a compact water-equivalent 2-channel plastic scintillation detector (Radius 0.5mm, Length 1mm, Volume 0.785mm³) for accurate photon and electron dose measurements across small and large field sizes. Designed for clinical medical physicists performing radiotherapy QA in hospitals. Available for commercial distribution in the United States, Japan, and South Korea.
- HYPERSCINT RP-200 A real-time, multi-point-ready, and versatile turnkey dosimetry tool leveraging plastic scintillators for time-resolved dosimetry of motion/gated applications (e.g., Adaptive-RT, MR-LINAC), small fields, and multi-met End-to-End testing. Designed for medical physics researchers at academic institutions and hospitals conducting advanced radiotherapy research. Available for commercial distribution worldwide for research purposes.
- HYPERSCINT RP-FLASH A second-generation Ultra-High-Speed Plastic Scintillation Dosimetry Solution designed for FLASH (Ultra-High Dose-Rate/UHDR) radiotherapy applications. Once calibrated at conventional dose-rate, it precisely measures dose-per-pulse, average dose-rate, and integrated dose for QA of FLASH irradiators. Designed for advanced radiotherapy research groups. Available for research purposes worldwide.
- PRO Series Scintillation Detector (1CH / 2CH / 4CH) High-precision scintillation detectors with a sharp 1mm² active area, waterproof design for multiple QA setups. Supports simultaneous single (1CH) or multi-point (2CH or 4CH) real-time dose measurements for End-to-End validation and Adaptive-RT QA. Designed for clinical medical physicists and researchers.
- MICRO Series Detector Ultra-small scintillator (0.5x0.5mm) for best precision in ultra-small fields thanks to ultra-low volume averaging. Designed for field sizes below 5mm including mini beams and spatially fractionated radiotherapy (SFRT). Targeted at advanced radiotherapy researchers.
- FLEX Series Detector Flexible scintillation detector design for measurements in restricted areas such as catheters or small animal phantoms. One model fits within 6FR catheters; another more rigid model fits within 2mm openings. Targeted at specialized research and clinical applications including brachytherapy and small animal irradiators.
- FLASH Series Detector Radiation-hard scintillation detector engineered for Ultra-High Dose-Rate (UHDR) applications. Capable of measuring dose per pulse, average dose-rate, and integrated dose simultaneously. Designed for FLASH radiotherapy research groups.
- MODULES Series Scintillation Detector Fully integrated scintillation detector (single or multiple points) for real-time and seamless performances in advanced setups such as adaptive radiotherapy. Includes the MRI4D Scintillation Detector Cassette with 4 PRO Series scintillators compatible with IBA QUASAR MRI4D Motion Phantom for MR-guided radiotherapy QA and latency measurements on Elekta Unity MR-Linac systems.
Quantifiable outcome
- Near-unity correction factors (1.002 to 0.999) across field sizes between 0.6×0.6 cm² and 30×30 cm² with 0.5% total uncertainty
- +2 more outcomes
Companies that use Medscint
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles2 records
Medscint technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature9 records
Medscint partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered minor, strategic, regional and core.
- Québec Tech Stage Vo ProgramminorSelected among seven innovative startups to join program complementary to Stage V that supports high-potential companies in international growth.
- Mayo Clinic Innovation ExchangestrategicMembership in Mayo Clinic Innovation Exchange program that fosters breakthrough innovation by connecting healthcare entrepreneurs, startups, and experts.
- EnergyFlow Inc.regionalStrategic distribution partnership for advanced radiotherapy QA solutions in South Korea. EnergyFlow is an independent provider of solutions and consultancy services.
- DosimETrICAregionalDistribution partnership for innovative radiotherapy QA solutions in Italy. DosimETrICA is a renowned independent supplier of dosimetry tools and consultancy in Radiotherapy, Radiology, and Medical Physics.
- Fimecorp International s.l.regionalDistribution agreement for plastic scintillation quality assurance equipment in Spain. Fimecorp is a major and trusted independent provider of medical equipment and software.
- Radicare b.v.regionalDistribution partnership for plastic scintillation dosimetry solutions in BENELUX region (Belgium, Netherlands, Luxembourg).
- Oncology Systems Limited (OSL)regionalDistribution agreement for plastic scintillation quality assurance equipment. OSL is a major and trusted independent provider of medical equipment and software to the radiotherapy community.
- Medical Alley AssociationcoreU.S. Go-to-Market program to help Medscint expand into the US market. Part of inaugural cohort of 10 medical device and digital health companies selected from nearly 30 applicants.
- IBA QUASAR (Modus Medical Devices)coreCollaboration on MRI4D Scintillation Detector Cassette integrating 4 Medscint scintillators compatible with IBA QUASAR MRI4D Motion Phantom for MRgRT QA.
- Université LavalcoreAcademic partnership with Université Laval through which many team members are trained and multiple research collaborations are conducted. Founding scientific community behind the technology.
- CHU de QuébeccoreMajor research and clinical partnership. CHU de Québec team members collaborate on product development and serve as key beta testing site.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Medscint competitors and assessment
Company assessmentDirect peers
- RTI Group: RTI Group (Sweden) manufactures X-ray QA meters, multimeters, and detectors for radiology and radiotherapy QA. Comparable in size and product category to Medscint, with a similar focus on real-time, multi-purpose measurement hardware.
- Modus Medical Devices: Modus Medical Devices manufactures QA phantoms and devices (such as the QUASAR MRI4D Motion Phantom) used in radiotherapy, with which Medscint's MRI4D scintillation cassette integrates. Direct peer in radiotherapy QA tooling and a channel/integration partner rather than a head-to-head substitute in scintillation.
- Capintec: Capintec manufactures radiation measurement and dose calibrator equipment, including ionization chambers and nuclear medicine instrumentation. Overlaps with Medscint on detector-based measurement devices sold into radiation medicine end markets.
- Standard Imaging: Standard Imaging (now part of PTW Dosimetry) designs and manufactures QA instruments and phantoms for radiotherapy, including electrometers, ion chambers, and the daily QA portfolio used at linac consoles. Directly comparable to Medscint's radiotherapy QA offering for clinical centers.
- PTW Freiburg: PTW is the global leader in radiation dosimetry, manufacturing ionization chambers, diamond detectors, and reference-class QA equipment used in radiotherapy and radiology. It is Medscint's most direct and largest competitor across clinical dosimetry product lines.
- IBA Dosimetry: IBA Dosimetry is a major vendor of dosimetry equipment for radiation therapy and radiology, including ionization chambers, detectors, and QA software. Notable here because IBA's QUASAR MRI4D Motion Phantom is a current Medscint integration partner, evidencing its position as a comparable physical-phantom and QA vendor.
- Sun Nuclear (Mirion Technologies): Sun Nuclear (now under Mirion) supplies patient QA hardware, phantoms, and software for radiotherapy and diagnostic imaging - including the IC Profiler, MapCHECK, and PerFRACTION portfolios. A direct peer in radiotherapy QA, now operating with Mirion's broader radiation detection scale.
- CIRS (Computerized Imaging Reference Systems): CIRS designs tissue-equivalent phantoms and QA products for radiology and radiotherapy, used for dose verification, image quality, and end-to-end testing. Direct peer in physical QA tooling for radiation therapy and a relevant point of comparison for end-to-end QA workflow positioning.
- Best Medical (CIVCO): Best Medical manufactures QA devices for external beam therapy, brachytherapy, and IMRT, including ionization chambers, phantoms, and detector arrays. Direct peer in clinical radiotherapy dosimetry hardware with overlapping hospital customer base.
Broad incumbents
- Fluke Health Solutions (Radiation Detection): Fluke Biomedical (now part of Fluke Health Solutions) provides broad biomedical and radiation QA equipment including dosimeters and survey meters. A broader incumbent with a wide QA portfolio that overlaps with Medscint's radiotherapy QA category but does not specifically target scintillation-based small-field dosimetry.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Medscint social profiles
Digital presenceMedscint financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medscint leadership team
Management profileNumber of profiles
Profiles12 records
Medscint funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medscint M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medscint
What does Medscint do?
Medscint designs, manufactures, and sells plastic scintillation dosimetry systems for radiotherapy quality assurance. Its flagship HYPERSCINT QA is a 2-channel medical device for clinical small-field dosimetry and End-to-End QA, commercially distributed in the United States, Japan, and South Korea. The HYPERSCINT Research Platform (RP-200 and RP-FLASH variants) provides turnkey, real-time, multi-point dosimetry for advanced radiotherapy research including MR-LINAC, Adaptive-RT, and FLASH (Ultra-High Dose-Rate) applications. The portfolio is complemented by a modular detector series (PRO, MICRO, FLEX, FLASH, MODULES) and the HYPERDOSE QA Software for real-time visualization.
Is Medscint a public or private company?
Medscint is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Medscint founded?
Medscint was founded in 2018. It employs 1 to 10 people.
Where is Medscint based?
Medscint is headquartered in Quebec, Canada, in the North America region.
How does Medscint make money?
Three revenue lines are on record. Medical Device Sales (HYPERSCINT QA) is the primary driver. The others are research Platform Sales (HYPERSCINT RP-200 and RP-FLASH) and custom Detector Solutions.
Who are Medscint's main competitors?
Direct peers on record are RTI Group, Modus Medical Devices, Capintec, Standard Imaging, PTW Freiburg, IBA Dosimetry, Sun Nuclear (Mirion Technologies), CIRS (Computerized Imaging Reference Systems) and Best Medical (CIVCO). Fluke Health Solutions (Radiation Detection) is listed as a broad incumbent.
Does Medscint have an API?
No public API is recorded for Medscint.
What industry is Medscint in?
Medscint's product category is Radiotherapy Dosimetry Equipment. Its primary akta.pro industry code is HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems, with a secondary code of HLACALAL, Quality, Peer Review & Compliance Tools (MQSA/ACR/QA). Its NAICS code is 334510 and its SIC code is 3845.